Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
0.960
+0.033 (3.57%)
Mar 11, 2025, 4:00 PM EST - Market closed
Fate Therapeutics Stock Forecast
FATE's stock price has decreased by -88.18% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Fate Therapeutics stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 472.98% from the current stock price of 0.96.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Fate Therapeutics stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 8 | 6 | 6 | 6 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 11 | 11 | 11 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +212.53% | Mar 6, 2025 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +420.89% | Mar 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +316.71% | Mar 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 19, 2024 |
Financial Forecast
Revenue This Year
3.79M
from 13.63M
Decreased by -72.22%
Revenue Next Year
2.93M
from 3.79M
Decreased by -22.66%
EPS This Year
-1.72
from -1.64
EPS Next Year
-1.54
from -1.72
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0M | 21.0M | 29.0M | ||
| Avg | 3.8M | 2.9M | 16.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 54.1% | 454.5% | 889.4% | ||
| Avg | -72.2% | -22.7% | 452.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.84 | -0.99 | -0.96 | ||
| Avg | -1.72 | -1.54 | -0.96 | ||
| Low | -2.03 | -2.16 | -0.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.